mailed
on 16 Dec 2024
Last Applicant/ Owned by
Abington Hall, Granta Park
Cambridge
GB
CB216AL
Serial Number
98081081 filed on 12th Jul 2023
Registration Number
N/A
Correspondent Address
Stacy J. Grossman
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring co Read More
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories
N/A
N/A
Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; excluding services related to RNA-based gene silencing and hepatocyte-specific computational biology
N/A
N/A
Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collecting, analyzing and organizing data in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data; excluding software and devices for RNA-based gene silencing and hepatocyte-specific computational biology
N/A
N/A
Pharmaceutical preparations for protection and prevention of viral and bacterial infections, cancer, infectious and non-infectious diseases and inflammation; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes, namely, for protection and prevention of viral and bacterial infections, cancer, infectious and non-infectious diseases and inflammation; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for protection and prevention of viral and bacterial infections, cancer, infectious and non-infectious diseases and inflammation; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infections, cancer, infectious and non-infectious diseases and inflammation; immunotherapeutic drugs namely, pharmaceutical preparations for protection and prevention of viral and bacterial infections, cancer, infectious and non-infectious diseases and inflammation; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; excluding preparations for RNA-based gene silencing
N/A
N/A
No 98081081
No Service Mark
No
Yes
Yes
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
16th Dec 2024 | LETTER OF SUSPENSION E-MAILED |
16th Dec 2024 | SUSPENSION LETTER WRITTEN |
16th Dec 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
07th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
07th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
07th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
09th Oct 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
09th Oct 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
10th Jul 2024 | NON-FINAL ACTION E-MAILED |
10th Jul 2024 | NON-FINAL ACTION WRITTEN |